[go: up one dir, main page]

GB201508733D0 - Antisense oligonucleotides - Google Patents

Antisense oligonucleotides

Info

Publication number
GB201508733D0
GB201508733D0 GBGB1508733.1A GB201508733A GB201508733D0 GB 201508733 D0 GB201508733 D0 GB 201508733D0 GB 201508733 A GB201508733 A GB 201508733A GB 201508733 D0 GB201508733 D0 GB 201508733D0
Authority
GB
United Kingdom
Prior art keywords
antisense oligonucleotides
antisense
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1508733.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics BV
Original Assignee
ProQR Therapeutics BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics BV filed Critical ProQR Therapeutics BV
Priority to GBGB1508733.1A priority Critical patent/GB201508733D0/en
Publication of GB201508733D0 publication Critical patent/GB201508733D0/en
Priority to AU2016265457A priority patent/AU2016265457B2/en
Priority to JP2017560600A priority patent/JP6871175B2/en
Priority to MX2017014855A priority patent/MX394185B/en
Priority to HK18105119.5A priority patent/HK1245826A1/en
Priority to PCT/EP2016/061495 priority patent/WO2016185041A1/en
Priority to US15/575,559 priority patent/US10370660B2/en
Priority to EP16724048.0A priority patent/EP3298144A1/en
Priority to CN201680029306.7A priority patent/CN107667174B/en
Priority to EA201792406A priority patent/EA036393B1/en
Priority to CA2986642A priority patent/CA2986642A1/en
Priority to NZ737592A priority patent/NZ737592B2/en
Priority to IL255180A priority patent/IL255180B2/en
Priority to KR1020177032446A priority patent/KR20180012255A/en
Priority to US16/442,912 priority patent/US11104900B2/en
Priority to JP2021068721A priority patent/JP7188804B2/en
Ceased legal-status Critical Current

Links

GBGB1508733.1A 2015-05-21 2015-05-21 Antisense oligonucleotides Ceased GB201508733D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1508733.1A GB201508733D0 (en) 2015-05-21 2015-05-21 Antisense oligonucleotides
KR1020177032446A KR20180012255A (en) 2015-05-21 2016-05-20 Antisence oligonucleotides to treat Dystrophic epidermolysis bullosa
US15/575,559 US10370660B2 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat Dystrophic Epidermolysis Bullosa
CN201680029306.7A CN107667174B (en) 2015-05-21 2016-05-20 Antisense oligonucleotides for treating dystrophic epidermolysis bullosa
MX2017014855A MX394185B (en) 2015-05-21 2016-05-20 ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF DYSTROPHIC EPIDERMOLYSIS BULLOSA.
HK18105119.5A HK1245826A1 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
PCT/EP2016/061495 WO2016185041A1 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
AU2016265457A AU2016265457B2 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
EP16724048.0A EP3298144A1 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
JP2017560600A JP6871175B2 (en) 2015-05-21 2016-05-20 Antisense oligonucleotide for treating dystrophy-type epidermolysis bullosa
EA201792406A EA036393B1 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
CA2986642A CA2986642A1 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
NZ737592A NZ737592B2 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
IL255180A IL255180B2 (en) 2015-05-21 2016-05-20 Antisense oligonucleotides for the treatment of vesicular dissolution of dystrophic skin
US16/442,912 US11104900B2 (en) 2015-05-21 2019-06-17 Antisense oligonucleotides to treat dystrophic epidermolysis bullosa
JP2021068721A JP7188804B2 (en) 2015-05-21 2021-04-14 Antisense oligonucleotides for treating dystrophic epidermolysis bullosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1508733.1A GB201508733D0 (en) 2015-05-21 2015-05-21 Antisense oligonucleotides

Publications (1)

Publication Number Publication Date
GB201508733D0 true GB201508733D0 (en) 2015-07-01

Family

ID=53506137

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1508733.1A Ceased GB201508733D0 (en) 2015-05-21 2015-05-21 Antisense oligonucleotides

Country Status (1)

Country Link
GB (1) GB201508733D0 (en)

Similar Documents

Publication Publication Date Title
IL257091B (en) Targeted oligonucleotides
IL256634A (en) Therapeutic oligonucleotides
IL256169A (en) Defined multi-conjugate oligonucleotides
IL253893A0 (en) Variant rnai
GB201711809D0 (en) Antisense oligonucleotide
ZA201700142B (en) Antisense nucleic acids
ZA201605864B (en) Antisense nucleic acids
IL258065B (en) Antisense nucleic acids
GB201503408D0 (en) Oligonucleotides
IL257921A (en) Combination comprising immunostimulatory oligonucleotides
GB201520997D0 (en) Dispensers
GB201518910D0 (en) Dispensers
GB201507926D0 (en) Improved treatments using oligonucleotides
SG10201913477UA (en) G-quadruplex-containing antisense oligonucleotides
GB201504124D0 (en) Oligonucleotides
SG10201911369PA (en) Oligonucleotides comprising modified nucleosides
GB201517241D0 (en) DNA modification
SG10201609048RA (en) Antisense oligonucleotides
PL3329004T3 (en) Therapeutic oligonucleotides
SG11201700652PA (en) Modified antimir-138 oligonucleotides
GB201714330D0 (en) Oligonucleotides
GB201516505D0 (en) Antisense oligonucleotides
GB201508733D0 (en) Antisense oligonucleotides
EP3323892A4 (en) Antisense oligonucleotide inhibiting 2gpi expression
GB201502629D0 (en) Concept A1

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)